| 摘要 |
The presenten invention also relates to a liquid immunoglobulin G (IgG) product which has a purity of more than 95%, a content of IgG monomers and dimers of at least 95% and, a content of IgA of less than 6 mg of IgA/I. The liquid product is stable and ready for instant intravenous administration. |
